Bloodless surgery in urologic oncology: A review of hematologic, anesthetic, and surgical considerations.
Aaron S Dahmen, Vania H Phuoc, Jonathan B Cohen, Wade J Sexton, Sephalie Y Patel
Author Information
Aaron S Dahmen: Department of Urology, University of Chicago, Chicago, IL.
Vania H Phuoc: Department of Medical Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Jonathan B Cohen: Department of Anesthesiology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Wade J Sexton: Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Sephalie Y Patel: Department of Anesthesiology, Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address: Sephalie.Patel@moffitt.org.
The urologic oncology patient who refuses blood transfusion can present unique challenges in perioperative blood management. Since blood loss and associated transfusion can be expected in many complex urologic oncology surgeries, a multidisciplinary approach may be required for optimal outcomes. Through collaboration with the hematologist, anesthesiologist, and urologist, various techniques can be employed in the perioperative phases to minimize blood loss and the need for transfusion. We review the risks and benefits of these techniques and offer recommendations specific to the urologic oncology patient.
